This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Should You Invest in the Invesco Water Resources ETF (PHO)?
by Zacks Equity Research
Sector ETF report for PHO
Danaher (DHR) to Acquire Abcam, Boost Life Sciences Unit
by Zacks Equity Research
Danaher (DHR) is set to acquire Abcam in a $5.7 billion deal, boosting its Life Sciences portfolio while solving some of the world's greatest healthcare challenges.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $255.53 in the latest trading session, marking a +0.78% move from the prior day.
Abbott (ABT) Gains in Core Diagnostics With FDA Nod for Alinity H
by Zacks Equity Research
Abbott's (ABT) Alinity h-series not only delivers technological innovation but also addresses the realistic challenges faced by modern healthcare systems.
Honeywell (HON) Beats on Q2 Earnings, Lifts 2023 Guidance
by Zacks Equity Research
Honeywell's (HON) Q2 results benefit from growth in commercial aerospace, process solutions and UOP business. The company improves its 2023 sales, segment margin and earnings guidance.
Danaher (DHR) Q2 Earnings Beat, Sales Decline 7.7% Y/Y
by Zacks Equity Research
Danaher's (DHR) Q2 earnings and revenues beat estimates. However, a decline in the sale of COVID-related products weigh on the top line.
Danaher (DHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Danaher (DHR) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 2.50% and 0.83%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $240.79, moving +1.27% from the previous trading session.
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $237.76, moving -1.15% from the previous trading session.
Will Low COVID-Testing Volumes Mar Danaher's (DHR) Q2 Earnings?
by Zacks Equity Research
Lower demand for COVID-19 testing, vaccine and therapeutics is expected to have hurt Danaher's (DHR) Q2 performance. Rising cost of sales might have hurt the bottom line.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $237.67, moving +1.36% from the previous trading session.
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $236.81 in the latest trading session, marking a -1.33% move from the prior day.
Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PIO
Should You Invest in the Invesco Global Water ETF (PIO)?
by Zacks Equity Research
Sector ETF report for PIO
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $233.80, moving -1.72% from the previous trading session.
Danaher (DHR) Shares Decline 10% YTD: What's Pulling It Down?
by Zacks Equity Research
Lower demand for COVID-19 testing, vaccine and therapeutics within the Biotechnology and Diagnostics segments weigh on Danaher (DHR).
Bear Of The Day: Danaher (DHR)
by Brian Bolan
Despite a great history of beating the number, this stock is a Zacks Rank #5 (Strong Sell) as earnings estimates have fallen.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $237.71, marking a +0.47% move from the previous day.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $241.27 in the latest trading session, marking a +1.35% move from the prior day.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $237.52 in the latest trading session, marking a +1.22% move from the prior day.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $232.69, marking a +1.34% move from the previous day.
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $232.21, moving +0.76% from the previous trading session.
Honeywell (HON) Beats on Q1 Earnings, Raises FY23 Guidance
by Zacks Equity Research
Honeywell's (HON) Q1 results benefit from strong performance of the Aerospace segment due to higher commercial aviation aftermarket sales. The company's improved guidance for 2023 holds promise.
Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PIO